Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
This concise intro highlights Which Dividend Etfs Are Most Tax Efficient, comparing key tax drivers and practical selection tips.
25,205 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Sabre, a travel-technology stalwart, is navigating a recovering travel market and shifting tech spend. This article b...
A sweeping housing proposal could unlock an easier path to ownership for many Americans. This guide breaks down what ...
Could XRP break the $5 barrier by 2026? This article breaks down the drivers, timelines, and practical steps for inve...
A nationwide poll in 2026 shows that remorse among Trump supporters is strongest among the swing voters who gave him ...
A hypothetical partnership could redirect USDC yield to buybacks, potentially lifting Hyperliquid's value. This guide...
If you want to know how a high-speed blockchain could beat Bitcoin in a multi-year window, this guide breaks down the...
Big investors and institutions are reshaping how people buy homes. This article explains the concept of wall street l...
Meet Ornith, the open-source coding model built for agents rather than humans. This article breaks down how it works,...
A looked-at moment in media power and money: how a public challenge can ripple into legal fees, PR costs, and real-wo...
Investor confidence is up—what’s making headlines? This article breaks down the forces behind a sunnier mood, what it...
Oracle stock swung wildly last month as AI hype collided with fundamentals. This guide explains what happened, why it...